Nebivololo e Idroclorotiazide EG

Nebivololo e Idroclorotiazide EG is a pharmaceutical product used for the treatment of essential hypertension. It combines a beta-blocker (Nebivolol) with a diuretic (Hydrochlorothiazide). The product is part of the generic portfolio of EG S.p.A., a prominent pharmaceutical company in Italy.

EG S.p.A. (EuroGenerici) was founded in Italy and is a member of the STADA Group, an international pharmaceutical giant headquartered in Germany. Manufacturing of these generic drugs often occurs across several of STADA's production facilities located in Europe and Asia to ensure wide distribution and cost-effectiveness. The brand represents a significant presence in the Italian generic medicine market, adhering to strict European safety and quality standards.